tirzepatide egfr 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( At a glance factsheet: Tirzepatide

In fact, some studies have suggested that GLP-1 receptor agonists may have anti-cancer properties , particularly in colon and breast cancers due to their effects on insulin regulation

It has the ability to detoxify the body from heavy metals, dangerous radicals and toxic substances

Association Between GLP-1 Receptor Agonists and Atrial Fibrillation Adverse Events: A Systematic Review and Meta-Analysis of Randomized Trials

That means fewer highs and lows, less mindless snacking, and a more stable, in-control feeling throughout the day

The GIC provides insurance for more than 460,000 public employees and retirees, and some 22,000 GIC members take GLP-1 drugs for weight loss at a total cost of $46 million